GeminIQ Website Logo

Viewing TCBPY free

Subscribe for full history, 90+ metrics, screener, watchlist...

TC BioPharm (Holdings) plc

TCBPY

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2024-03-31
2023-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
12
Prepaid Expense And Other Assets Current
22
Assets Current
46
Assets Noncurrent
Property Plant And Equipment Net
11
Operating Lease Right Of Use Asset
11
Intangible Assets Net Excluding Goodwill
11
Assets
79
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current
44
Derivative Liabilities Current
00
Operating Lease Liability Current
00
Liabilities Current
55
Operating Lease Liability Noncurrent
11
Liabilities
66
Stockholders Equity
Common Stock Value
00
Additional Paid In Capital
4341
Retained Earnings Accumulated Deficit
-42-39
Stockholders Equity
13
Liabilities And Stockholders Equity
79
Common Stock Par Or Stated Value Per Share
00
Common Stock Shares Authorized
00
Common Stock Shares Issued
00
Shares Outstanding
00

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2024-3.57%-20.65%-61.43%---
2023---20.47%-11.02%-31.51%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2024-03-31
2023-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.88
1.20
Quick Ratio
0.45
0.74
Working Capital
-560.82K
950.33K
Leverage & Debt
Debt to Equity
5.72
2.33
Debt Ratio
0.85
0.70
Calculated Values
Net Debt
-980.96K
-2.46M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2022-11-30Purchase
Owner: Renaissance, Capital Part…
Title: -
Shares: 70,000
Price/Share: $5.00
Value: $350,000.00
Shares Owned: 136,834
Relationship: TenPercentOwner
Ownership: Direct
2022-11-30Purchase
Owner: Randall, Kenneth Edward
Title: -
Shares: 70,000
Price/Share: $5.00
Value: $350,000.00
Shares Owned: 136,834
Relationship: TenPercentOwner
Ownership: Indirect
2022-11-30Purchase
Owner: Randall, Diana Elizabeth
Title: -
Shares: 70,000
Price/Share: $5.00
Value: $350,000.00
Shares Owned: 70,000
Relationship: TenPercentOwner
Ownership: Indirect
2022-11-30Purchase
Owner: Randall, Mark Edward
Title: -
Shares: 70,000
Price/Share: $5.00
Value: $350,000.00
Shares Owned: 136,834
Relationship: TenPercentOwner
Ownership: Indirect
2022-05-24Purchase
Owner: Randall, Kenneth Edward
Title: -
Shares: 20,803
Price/Share: $1.15
Value: $23,923.45
Shares Owned: 100,418
Relationship: TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2023-09-30
-
Inst. Shares: 421,835
Shares Outstanding: 1,545

TC BioPharm (Holdings) plc (TCBPY) — SEC Financial Statements & Analysis

TC BioPharm (Holdings) plc (TCBPY) is a biological products, (no diagnostic substances) company, incorporated in X0. TC BioPharm (Holdings) plc trades on OTC as: TCBPY, TCBWF. Based on its latest SEC filing (Form 10-Q, period ending 2024-03-31), TC BioPharm (Holdings) plc reported a Debt-to-Equity ratio of 5.72x. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
5.72x

Data as of 2024-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is TC BioPharm (Holdings) plc in?

TC BioPharm (Holdings) plc (TCBPY) operates in the Biological Products, (No Diagnostic Substances) industry.

What exchange does TCBPY trade on?

TC BioPharm (Holdings) plc (TCBPY) trades on the OTC.

Where is TC BioPharm (Holdings) plc incorporated?

TC BioPharm (Holdings) plc is incorporated in United Kingdom.

Wall Street's data.
Main Street's price.